Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease

Effective, safe, and pharmacokinetically suitable drugs are urgently needed to curb the ongoing COVID-19 pandemic. The main protease or 3C-like protease (M(pro) or 3CL(pro)) of SARS-CoV-2 is considered an important target to formulate potent drugs corresponding to its crucial role in virus replicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengist, Hylemariam Mihiretie, Mekonnen, Daniel, Mohammed, Ahmed, Shi, Ronghua, Jin, Tengchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883113/
https://www.ncbi.nlm.nih.gov/pubmed/33597888
http://dx.doi.org/10.3389/fphar.2020.630500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883113/
https://www.ncbi.nlm.nih.gov/pubmed/33597888
http://dx.doi.org/10.3389/fphar.2020.630500

Ejemplares similares